BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7045370)

  • 1. Renin inhibitors. Substitution of the leucyl residues of Leu-Leu-Val-Phe-OCH3 with 3-amino-2-hydroxy-5-methylhexanoic acid.
    Johnson RL
    J Med Chem; 1982 May; 25(5):605-10. PubMed ID: 7045370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of renin by angiotensinogen peptide fragments containing the hydroxy amino acid residue 5-amino-3-hydroxy-7-methyloctanoic acid.
    Johnson RL; Verschoor K
    J Med Chem; 1983 Oct; 26(10):1457-62. PubMed ID: 6352942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(alpha-Hydroxyalkanoyl) derivatives of Leu-Val-Phe-OCH3 as inhibitors of renin.
    Johnson RL
    J Med Chem; 1980 Jun; 23(6):666-9. PubMed ID: 6993683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of renin by substrate analogue inhibitors containing the olefinic amino acid 5(S)-amino-7-methyl-3(E)-octenoic acid.
    Johnson RL
    J Med Chem; 1984 Oct; 27(10):1351-4. PubMed ID: 6384520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
    Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
    J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
    Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
    J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renin inhibitors. Syntheses of subnanomolar, competitive, transition-state analogue inhibitors containing a novel analogue of statine.
    Boger J; Payne LS; Perlow DS; Lohr NS; Poe M; Blaine EH; Ulm EH; Schorn TW; LaMont BI; Lin TY
    J Med Chem; 1985 Dec; 28(12):1779-90. PubMed ID: 3906131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of rat renin inhibitory peptides.
    Hui KY; Holtzman EJ; Quinones MA; Hollenberg NK; Haber E
    J Med Chem; 1988 Sep; 31(9):1679-86. PubMed ID: 3045320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
    TenBrink RE; Pals DT; Harris DW; Johnson GA
    J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of some transition-state inhibitors of human renin.
    Bühlmayer P; Caselli A; Fuhrer W; Göschke R; Rasetti V; Rüeger H; Stanton JL; Criscione L; Wood JM
    J Med Chem; 1988 Sep; 31(9):1839-46. PubMed ID: 3137345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
    Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
    J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the reaction of renin with nine synthetic peptide substrates.
    Skeggs LT; Lentz KE; Kahn JR; Hochstrasser H
    J Exp Med; 1968 Jul; 128(1):13-34. PubMed ID: 5662012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Active site directed inactivators of mouse submaxillary renin.
    Suketa Y; Inagami T
    Biochemistry; 1975 Jul; 14(14):3188-94. PubMed ID: 1148198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.
    Maibaum J; Rich DH
    J Med Chem; 1988 Mar; 31(3):625-9. PubMed ID: 3126296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cathepsin D by substrate analogues containing statine and by analogues of pepstatin.
    Agarwal NS; Rich DH
    J Med Chem; 1986 Dec; 29(12):2519-24. PubMed ID: 3783611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of analogues of the carboxyl protease inhibitor pepstatin. Effects of structure on inhibition of pepsin and renin.
    Rich DH; Sun ET; Ulm E
    J Med Chem; 1980 Jan; 23(1):27-33. PubMed ID: 6767029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the specificity of human renin. Studies with peptide inhibitors.
    Poulsen K; Haber E; Burton J
    Biochim Biophys Acta; 1976 Dec; 452(2):533-7. PubMed ID: 1009126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatically stable renin inhibitors containing statine and 6 aminohexanoic acid. Part IV.
    Paruszewski R; Jaworski P; Tautt J; Dudkiewicz J
    Boll Chim Farm; 1994 May; 133(5):301-8. PubMed ID: 8068237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renin inhibitors containing statine and 6-aminohexanoic acid. Part III.
    Paruszewski R; Tautt J; Dudkiewicz J
    Pol J Pharmacol; 1993; 45(1):75-82. PubMed ID: 8401762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive inhibitors of renin. Inhibitors effective at physiological pH.
    Burton J; Poulsen K; Haber E
    Biochemistry; 1975 Aug; 14(17):3892-8. PubMed ID: 240395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.